Observational studyMedicine2019

Retrospective evaluation of the efficacy and safety of rivaroxaban in patients with cancer-associated venous thromboembolism: A single-center study.

Sang-Bo Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.